Search Results 141-150 of 17080 for pharmacogenetics
The purpose of this study is to establish an opioid and multiple addiction (OMA) biobank that creates a comprehensive standard patient phenotype using ...
About this study. A group of Mayo Clinic Biobank participants were genotyped for genetic variants as part of a separate study and a subset were found to be ...
An error occurred, please try again later. Copy for customer care: session ID undefined. Try again. Share · Tweet . VID-20423891.
Dasburg Professor in Cancer Genomics Research at Mayo Clinic in Rochester. He is a pioneer in pharmacogenetics, and his continuing translational work in ...
The purpose of this study is to provide descriptive information on patients with hereditary hemochromatosis, including their predominant symptoms, time to ...
Pharmacogenetics in hemostasis: friend or foe? Semin Thromb Hemost. 2009 Feb; 35(1):42-9 Epub 2009 Mar 23. View PubMed; Rumilla KM, Erickson LA, Service FJ ...
Assess outcome differences in two groups of pediatric patients with chronic pain. Review the perceived effectiveness and clinical utility of PGx testing on ...
Faculty and staff of the Pharmacogenomics Lab of Richard Weinshilboum, M.D., at Mayo Clinic's campus in Rochester, Minnesota.
MemberInvestigator Coordinating Committee, Pharmacogenetics Research Network, National Institutes of Health. 2002. MemberDirectors Search and Selection ...
Pharmacogenetics and novel pharmacotherapeutics. A major focus of Dr. Camilleri's lab is the development and testing of new medications for all the ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!